Psychedelic-Assisted therapy trial aims to transform PTSD treatment
NCT ID NCT07288151
Summary
This study is testing whether a single dose of MDMA (commonly known as ecstasy) given during intensive therapy sessions can help people with PTSD more than therapy alone. Researchers will enroll 200 adults with PTSD who will receive either MDMA or a placebo during their second therapy session, then track their symptoms for one month. The goal is to see if this combination leads to stronger and longer-lasting improvement in PTSD symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Emory Brain Health Center
Atlanta, Georgia, 30329, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.